Debt-to-equity of PROVECTUS BIOPHARMACEUTICALS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PROVECTUS BIOPHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • PROVECTUS BIOPHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -112%, a 2.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -112% +2.8% +2.4% 30 Sep 2025
Q2 2025 -114% +2.7% +2.3% 30 Jun 2025
Q1 2025 -114% +6% +5% 31 Mar 2025
Q4 2024 -114% +8% +6.6% 31 Dec 2024
Q3 2024 -115% +10% +8.4% 30 Sep 2024
Q2 2024 -117% +10% +8.2% 30 Jun 2024
Q1 2024 -120% +12% +8.9% 31 Mar 2024
Q4 2023 -122% 31 Dec 2023
Q3 2023 -125% 30 Sep 2023
Q2 2023 -127% 30 Jun 2023
Q1 2023 -131% 31 Mar 2023
Q4 2021 -113% -8.8% -8.5% 31 Dec 2021
Q3 2021 -104% +1.6% +1.5% 30 Sep 2021
Q2 2021 -103% +2.3% +2.2% 30 Jun 2021
Q1 2021 -104% +3.2% +3% 31 Mar 2021
Q4 2020 -104% +6.8% +6.2% 31 Dec 2020
Q3 2020 -105% +7.3% +6.5% 30 Sep 2020
Q2 2020 -106% +9.2% +8% 30 Jun 2020
Q1 2020 -107% +11% +9.2% 31 Mar 2020
Q4 2019 -111% +7.7% +6.5% 31 Dec 2019
Q3 2019 -112% +12% +9.4% 30 Sep 2019
Q2 2019 -115% +17% +13% 30 Jun 2019
Q1 2019 -118% +27% +19% 31 Mar 2019
Q4 2018 -119% 31 Dec 2018
Q3 2018 -124% 30 Sep 2018
Q2 2018 -132% 30 Jun 2018
Q1 2018 -145% 31 Mar 2018
Q4 2015 8.9% -5.6% -39% 31 Dec 2015
Q3 2015 5.1% -34% -87% 30 Sep 2015
Q2 2015 5.4% -46% -90% 30 Jun 2015
Q1 2015 7.3% -67% -90% 31 Mar 2015
Q4 2014 15% -75% -84% 31 Dec 2014
Q3 2014 39% -12% -23% 30 Sep 2014
Q2 2014 52% -11% -17% 30 Jun 2014
Q1 2014 74% -2.4% -3.1% 31 Mar 2014
Q4 2013 89% +14% +18% 31 Dec 2013
Q3 2013 51% -13% -21% 30 Sep 2013
Q2 2013 62% +12% +24% 30 Jun 2013
Q1 2013 76% +35% +85% 31 Mar 2013
Q4 2012 76% 31 Dec 2012
Q3 2012 64% 30 Sep 2012
Q2 2012 50% 30 Jun 2012
Q1 2012 41% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.